IL6 and prostate carcinoma: For instance, in mouse model of prostate cancer, depression is illuminated to increase the infiltration of myeloid cells and interleukin-6 (IL-6) expressions via mediating sympathetic neuropeptide Y (NPY) signaling pathway and subsequently enhances the tumor growth [27].